Logo.jpg
Endonovo Therapeutics Provides SofPulse® To All NFL Teams
23 déc. 2019 08h30 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
Logo.jpg
Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock
19 déc. 2019 18h24 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today that its previously announced 1-for-1,000 reverse split of...
Logo.jpg
Endonovo Therapeutics Announces Reverse Stock Split - UPDATE
11 déc. 2019 13h40 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Logo.jpg
Endonovo Therapeutics Announces Reverse Stock Split
11 déc. 2019 12h47 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Logo.jpg
Endonovo Therapeutics Reports Third Quarter 2019 Results
19 nov. 2019 16h35 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Logo.jpg
Endonovo Therapeutics Announces Reverse Stock Split
31 oct. 2019 12h43 HE | Endonovo Therapeutics, Inc.
 Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement...
Logo.jpg
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
30 sept. 2019 09h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to...
Logo.jpg
Endonovo Therapeutics and Veterans Healthcare Supply Solutions Announce Distribution Agreement
21 mai 2019 09h20 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, May 21, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) and Veterans Healthcare Supply Solutions Inc. (VHSS) today announced a long-term agreement encompassing...
Logo.jpg
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member
09 mai 2019 09h20 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA , May 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board...
Logo.jpg
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing
07 mai 2019 09h20 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, May 07, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position,...